BG104737A - Salts of paroxetine - Google Patents
Salts of paroxetineInfo
- Publication number
- BG104737A BG104737A BG104737A BG10473700A BG104737A BG 104737 A BG104737 A BG 104737A BG 104737 A BG104737 A BG 104737A BG 10473700 A BG10473700 A BG 10473700A BG 104737 A BG104737 A BG 104737A
- Authority
- BG
- Bulgaria
- Prior art keywords
- paroxetine
- salts
- methylbenzenesulphonioc
- propylaxis
- hypophosphorous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A salt of paroxetine with an acid selected from the group consisting of sulphuric, tartaric, oxalic, fumaric, propionic, formic, glutamic, succinic, benzoic, citric, phosphoric, 4-methylbenzenesulphonioc, hypophosphorous, lactic, and mandelic acids and glycine, is useful in the treatment and propylaxis of certain CNS disorders. 10 claims
Applications Claiming Priority (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802661.0A GB9802661D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802655.2A GB9802655D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802654.5A GB9802654D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802656.0A GB9802656D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802638.8A GB9802638D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802659.4A GB9802659D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802645.3A GB9802645D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802664.4A GB9802664D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802657.8A GB9802657D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802653.7A GB9802653D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802698.2A GB9802698D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802639.6A GB9802639D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802640.4A GB9802640D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802644.6A GB9802644D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802665.1A GB9802665D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802658.6A GB9802658D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9802646.1A GB9802646D0 (en) | 1998-02-06 | 1998-02-06 | Novel compounds |
GBGB9817321.4A GB9817321D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817360.2A GB9817360D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817317.2A GB9817317D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817307.3A GB9817307D0 (en) | 1998-08-08 | 1998-08-08 | Novel compound |
GBGB9817364.4A GB9817364D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817359.4A GB9817359D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817344.6A GB9817344D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817309.9A GB9817309D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817340.4A GB9817340D0 (en) | 1998-08-08 | 1998-08-08 | Novel compounds |
GBGB9817320.6A GB9817320D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9817322.2A GB9817322D0 (en) | 1998-08-10 | 1998-08-10 | Novel compounds |
GBGB9826173.8A GB9826173D0 (en) | 1998-11-30 | 1998-11-30 | Novel compounds |
GBGB9826172.0A GB9826172D0 (en) | 1998-11-30 | 1998-11-30 | Novel compound |
GBGB9827277.6A GB9827277D0 (en) | 1998-12-11 | 1998-12-11 | Novel compound |
GBGB9827341.0A GB9827341D0 (en) | 1998-12-11 | 1998-12-11 | Novel compounds |
GBGB9828775.8A GB9828775D0 (en) | 1998-12-29 | 1998-12-29 | Novel compounds |
PCT/GB1999/000380 WO1999040084A1 (en) | 1998-02-06 | 1999-02-05 | Salts of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104737A true BG104737A (en) | 2001-07-31 |
Family
ID=27586915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104737A BG104737A (en) | 1998-02-06 | 2000-08-30 | Salts of paroxetine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1053234A1 (en) |
JP (1) | JP2002505254A (en) |
KR (1) | KR20010040711A (en) |
BG (1) | BG104737A (en) |
CA (1) | CA2319652A1 (en) |
EA (1) | EA200000815A1 (en) |
IL (1) | IL137684A0 (en) |
NO (1) | NO20003960L (en) |
PL (1) | PL342295A1 (en) |
SK (1) | SK11812000A3 (en) |
WO (1) | WO1999040084A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (en) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it. |
GB9814316D0 (en) * | 1998-07-02 | 1998-09-02 | Smithkline Beecham Plc | Novel compounds |
EP1102764A1 (en) * | 1998-08-08 | 2001-05-30 | Smithkline Beecham Plc | Paroxetine salts |
GB9827431D0 (en) * | 1998-12-11 | 1999-02-03 | Smithkline Beecham Plc | Novel compound |
WO2000078290A2 (en) * | 1999-06-22 | 2000-12-28 | Smithkline Beecham P.L.C. | Pharmaceutical composition comprising a salt of paroxetine |
HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
EA200300770A1 (en) * | 2001-01-05 | 2003-10-30 | Эли Лилли Энд Компани | ANTAGONISTS OF EXCESSING AMINO ACID RECEPTORS |
US20040225128A1 (en) * | 2001-08-02 | 2004-11-11 | Callewaert George Leo | Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
KR100672184B1 (en) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | Paroxetine cholate or cholic acid derivative salts |
CN108218844B (en) * | 2018-03-08 | 2021-01-19 | 合肥科大生物技术有限公司 | Memantine paroxetine eutectic salt and preparation method, pharmaceutical composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
HU221921B1 (en) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them |
-
1999
- 1999-02-05 WO PCT/GB1999/000380 patent/WO1999040084A1/en not_active Application Discontinuation
- 1999-02-05 EP EP99904971A patent/EP1053234A1/en not_active Withdrawn
- 1999-02-05 CA CA002319652A patent/CA2319652A1/en not_active Abandoned
- 1999-02-05 KR KR1020007008591A patent/KR20010040711A/en not_active Application Discontinuation
- 1999-02-05 JP JP2000530513A patent/JP2002505254A/en active Pending
- 1999-02-05 PL PL99342295A patent/PL342295A1/en not_active Application Discontinuation
- 1999-02-05 EA EA200000815A patent/EA200000815A1/en unknown
- 1999-02-05 SK SK1181-2000A patent/SK11812000A3/en unknown
- 1999-02-05 IL IL13768499A patent/IL137684A0/en unknown
-
2000
- 2000-08-04 NO NO20003960A patent/NO20003960L/en not_active Application Discontinuation
- 2000-08-30 BG BG104737A patent/BG104737A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL342295A1 (en) | 2001-06-04 |
SK11812000A3 (en) | 2001-08-06 |
WO1999040084A1 (en) | 1999-08-12 |
EA200000815A1 (en) | 2001-02-26 |
EP1053234A1 (en) | 2000-11-22 |
JP2002505254A (en) | 2002-02-19 |
NO20003960D0 (en) | 2000-08-04 |
KR20010040711A (en) | 2001-05-15 |
IL137684A0 (en) | 2001-10-31 |
NO20003960L (en) | 2000-09-25 |
CA2319652A1 (en) | 1999-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG104737A (en) | Salts of paroxetine | |
EP1188822A4 (en) | L-amino acid-producing bacteria and process for producing l-amino acid | |
CA2268886A1 (en) | Aminothiophenecarboxamides | |
CA2255652A1 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
DE69921881D1 (en) | L-glutamic acid-producing bacterium and process for producing L-glutamic acid | |
CA2147341A1 (en) | Skin treatment composition comprising l-lactic acid and n-acetyl-l-cysteine | |
CA2304969A1 (en) | Mouth hygienic composition for the treatment of halitosis | |
YU2003A (en) | Stable salts of o-acetylsalicyclic acid with basic amino acids | |
ZA989014B (en) | Process for the microbial production of amino acids of the aspartate and/or glutamate family and means used in the process. | |
CA2333024A1 (en) | Method for the treatment of insomnia | |
AU562507B2 (en) | Lactic, acid salts of piperazinyl quinoline and azaquinoline carboxylic acids | |
SE9300758D0 (en) | PROCESS FOR THE PRODUCTION OF CLAVULANIC ACID | |
BG102814A (en) | New derivatives of carboxylic acid, their preparation and application | |
MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
EP0694528A3 (en) | Alkylenediamine-N,N'-disuccinic acid iron (III) complex salts and process for production thereof | |
TW355709B (en) | Quinoline carboxylic acid derivative | |
EP1052963A4 (en) | Compositions and methods of treating keratin-related disorders and conditions | |
AP2000001879A0 (en) | Salts of paroxetine. | |
HUP0301059A3 (en) | Use of lactic acid bacterium for the treatment of peritonitis | |
MX9504733A (en) | Process for metal cleaning. | |
BG105014A (en) | Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres | |
MY126743A (en) | Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis | |
PL365213A1 (en) | Enteric ketoacid salts and amino acids | |
ATE294584T1 (en) | USE OF DESOXYPEGANINE TO TREAT ALZHEIMER'S DEMENTIA | |
MX222729B (en) | Process for the Hydrolysis of Adiponitrile and the Production of Nylon 6,6 Using Dicarboxylic Acids as the Sole Catalyst |